D
Sell
3/14/2023Downgrade
MoonLake Immunotherapeutics (MLTX) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/23/2023Upgraded
MoonLake Immunotherapeutics (MLTX) was upgraded to D from D- on 2/23/2023 due to a noticeable increase in the total return index.
D
Sell
2/8/2023Downgrade
MoonLake Immunotherapeutics (MLTX) was downgraded to D- from D on 2/8/2023 due to a large decline in the efficiency index, valuation index and solvency index. The quick ratio declined from 24.18 to 13.97, and total capital declined 12.68% from $94.56M to $82.57M.
D
Sell
8/15/2022None
MoonLake Immunotherapeutics (MLTX) was downgraded to D from U on 08/15/2022.
